Adults with Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia: Considerations for Allogeneic Hematopoietic Cell Transplantation in First Complete Remission
Authors:
Open Access
- 1 February 2019
- journal article
- case report
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 25 (2) , e41-e45
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Targetable kinase gene fusions in high-risk B-ALL: a study from the Children’s Oncology GroupBlood, 2017
- Ph-like acute lymphoblastic leukemia: a high-risk subtype in adultsBlood, 2017
- High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in AdultsJournal of Clinical Oncology, 2017
- High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALLLeukemia, 2016
- Adults with Philadelphia chromosome–like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosisHaematologica, 2016
- Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse ratesHaematologica, 2015
- Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2014
- Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapseNature Genetics, 2013
- A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification studyThe Lancet Oncology, 2009
- Deletion ofIKZF1and Prognosis in Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2009